MedTrace Logo

Efficacy and Safety of Heme-Iron Polypeptide on Improvement of Anemia

NCT01733979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-08-26

No results posted yet for this study

Summary

The investigators performed a 4-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Heme-Iron Polypeptide on Improvement of Anemia. The investigators measured Improvement of Anemia parameters , including hemoglobin, transferrin saturation, serum iron, and ferritin, and monitored their blood pressure.

Conditions

Interventions

DIETARY_SUPPLEMENT

Heme-Iron Polypeptide

Heme-Iron Polypeptide (1g/day)

DIETARY_SUPPLEMENT

Placebo

Placebo (1g/day)

DIETARY_SUPPLEMENT

Heme-Iron

Heme-Iron (1g/day)

DIETARY_SUPPLEMENT

Organic Iron

Organic Iron (1g/day)

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-07
Primary Completion
2012-11-14
Completion
2012-11-14

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01733979 on ClinicalTrials.gov